Search results
1 company and 6 research reports found for "TopoTarget"
Company results
- TopoTarget
TopoTarget is a Danish drug development and marketing company focused on the field of oncology. Its ...
Sector reports
No sector reports have been found.
Research results
TopoTarget
Staying self-sufficient
Update | Pharmaceutical & Healthcare | 09/12/2011Topotarget is undergoing a restructuring so that it is not dependent on a fund-raising before the potential receipt of milestone payments from Spectru...
TopoTarget
Thoughts on belinostat
Update | Pharmaceutical & Healthcare | 30/08/2011The main potential for belinostat is in solid tumours, although it could gain approval initially in the haematological cancer, peripheral T-cell lymph...
TopoTarget
Look beyond the setback
Update | Pharmaceutical & Healthcare | 18/03/2011The recent clinical trial failure with belinostat in ovarian cancer does not undermine the investment case despite the share price falling by 20%. Imp...
TopoTarget
A data rich 2011
Update | Pharmaceutical & Healthcare | 20/01/2011Top-line data from several trials with TopoTarget’s key drug, belinostat, are expected throughout 2011. The most important results are from trials i...
TopoTarget
Betting on belinostat
Outlook | Pharmaceutical & Healthcare | 10/09/2010TopoTarget’s prospects are closely tied to those of its lead drug, belinostat. It is in a pivotal Phase II trial for peripheral T-cell lymphoma (PTC...
TopoTarget
Belinostat deal
QuickView | Pharmaceutical & Healthcare | 09/02/2010TopoTarget’s co-development deal with Spectrum Pharmaceuticals for its HDAC inhibitor belinostat, signed last week, looks to be a transformative ...
